Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-08-23, Stock:ABBV, The news for the past five days is as follows:
2019-08-16: NEWS1: How AbbVie Plans To Take On Pfizer, Lilly — And Kick Its Humira Habit.NEWS2: How Merck Could Ride 'The Keytruda Wave' To Dominate These Rivals.NEWS3: FDA approves AbbVie's Rinvoq to treat moderate-to-severe RA.NEWS4: UPDATE 2-AbbVie prices new rheumatoid arthritis drug at $59,000/yr.NEWS5: AbbVie Receives FDA Approval of RINVOQ™ (upadacitinib), an Oral JAK Inhibitor For The Treatment of Moderate to Severe Rheumatoid Arthritis.NEWS6: Gilead's (GILD) Filgotinib MAA for RA Accepted in Europe.NEWS7: Gilead's (GILD) Filgotinib MAA for RA Accepted in Europe.NEWS8: Gilead's (GILD) Filgotinib MAA for RA Accepted in Europe.
2019-08-19: NEWS1: Stocks To Buy: Is It Time To Buy Or Sell These Large-Cap Stocks?.NEWS2: AbbVie's JAK Inhibitor Rinvoq Receives FDA Approval for RA.NEWS3: AbbVie's JAK Inhibitor Rinvoq Receives FDA Approval for RA.NEWS4: AbbVie Rises 3%.NEWS5: AbbVie's JAK Inhibitor Rinvoq Receives FDA Approval for RA.NEWS6: 5 Biggest New Drug Approvals Potentially on the Way in 2019.
2019-08-20: NEWS1: Bayer Sells Animal Health Division to Elanco: Now What?.NEWS2: IXJ, LLY, ABBV, DHR: Large Outflows Detected at ETF.NEWS3: IXJ, LLY, ABBV, DHR: Large Outflows Detected at ETF.NEWS4: Here's Why Allergan is Outperforming Its Industry Of Late.NEWS5: Here's Why Allergan is Outperforming Its Industry Of Late.NEWS6: The Time is Right For This Dividend ETF.NEWS7: Buy AbbVie Stock Because You ‘Can’t Ignore’ How Cheap It Is.NEWS8: Here's Why Allergan is Outperforming Its Industry Of Late.NEWS9: AbbVie's Latest FDA Approval Is Its Most Important Immunology Win Since Humira.NEWS10: AbbVie's Latest FDA Approval Is Its Most Important Immunology Win Since Humira.NEWS11: AbbVie&apos;s Latest FDA Approval Is Its Most Important Immunology Win Since Humira.NEWS12: High-Dividend Stocks on Historic Discount as Yields Plunge, says Goldman.
2019-08-21: NEWS1: Synlogic Discontinues Development of SYNB1020, Stock Down.NEWS2: AbbVie Stock Slipped to a New Low, and One Exec Scooped Up Shares.NEWS3: Pot Entrepreneurs Can Now Get an MBA in Cannabis.NEWS4: Bayer Sells Animal Health Division to Elanco: Now What?.NEWS5: Bayer Sells Animal Health Division to Elanco: Now What?.
2019-08-22: NEWS1: Here's What You Should Know About AbbVie Inc.'s (NYSE:ABBV) 6.3% Dividend Yield.NEWS2: Synlogic Discontinues Development of SYNB1020, Stock Down.NEWS3: Synlogic Discontinues Development of SYNB1020, Stock Down.

Answer: Decrease